Biotech Sector: Support Levels To Watch No sector has exemplified these past few years of the cyclical bull market as much as biotechnology stocks. Likewise,…

Biotech Sector: Support Levels To Watch No sector has exemplified these past few years of the cyclical bull market as much as biotechnology stocks. Likewise,…
There is a fervent debate in some financial circles regarding the existence – or non-existence – of a biotech bubble. It is a challenging, and…
Biotech ETF IBB: Cup-&-Handle Breakout Enough said. ________ More from Dana Lyons, JLFMI and My401kPro.
Bull Flag Signaling 1 More Chance To Buy This Biotech ETF? Biotech stocks have alternated between hero and villain in 2014 (FYI, we have been…
The NYSE released their June margin debt update yesterday and it was a doozy. Margin debt jumped nearly 6% to just 0.3% shy of the…
We’ve discussed biotechs a lot lately both here and in our newsletters. They remain a big focus for us as a possible canary, considering their…
Two of the YTD performance leaders are the Biotechs ($BTK) and Semiconductors ($SOX), both up roughly 15%. However, the paths to that 15% return could…
On April 9, we pointed out a key Fibonacci Retracement cluster of support on the S&P SPDR Biotech ETF, $XBI (also generally corresponding with similar…
The SPDR Biotech ETF ($XBI) is nearing a major cluster of Fibonacci Retracement support around the 127 level. This may be the level from which…
Originally posted on 3/25/14: http://stks.co/d0McS